Gewinn- und Verlustrechnung von Option Care Health, Inc.

Option Care Health Inc. (NASDAQ:OPCH) agreed Tuesday to be taken private by Clayton Dubilier & Rice and McKesson Corp. (NYSE:MCK) for $32.05 a share in cash. The deal gives the home-infusion provider a total enterprise value of about $5.8 billion.

Option Care is being bought out by McKesson and private equity firm Clayton Dubilier & Rice. The deal values Option Care at $32.05 per share or about $5.8 billion.

Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Option Care Health, Inc. (NASDAQ: OPCH) to CD&R, McKesson Corporation for $32.05 per

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Option Care Health, Inc. (NASDAQ: OPCH) to CD&R, McKesson Corporation for $32.05 per share. Halper Sadeh encourages Option Care shareholders to click here to learn more about their rights and options or contact Daniel Sadeh or Zachary Halper free of charge at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com. The investigation concerns whether Option Care and its board of.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Private equity firm CD&R and McKesson Corporation (NYSE:MCK) on Tuesday agreed to acquire Option Care Health Inc. (NASDAQ:OPCH) for $32.05 per share.

BALA CYNWYD, Pa., Oct. 06, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.

Mckesson Corp (NYSE:MCK), the US healthcare services and drug distribution company, and Clayton Dubilier & Rice (CD&R), the private investment firm, have agreed to acquire Option Care Health (NASDAQ:OPCH) for approximately $5.8 billion. The buyers will pay $32.05 a share for Option Care Health, the largest independent provider of home and alternate-site infusion services in the US, representing a 37% premium to Monday's closing price.

NEW YORK & IRVING, Texas & BANNOCKBURN, Ill.--(BUSINESS WIRE)--CD&R, McKesson Corporation (NYSE: MCK) (“McKesson”), and Option Care Health, Inc. (Nasdaq: OPCH) (“Option Care Health”) announced today that they have entered into a definitive agreement, under which CD&R and McKesson will acquire Option Care Health, an independent provider of home and alternate site infusion services, for $32.05 per share, reflecting a total enterprise value of approximately $5.8 billion. At the closing of.

Humana (NYSE: HUM - Get Free Report) and Option Care Health (NASDAQ: OPCH - Get Free Report) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, valuation, earnings, dividends, risk, analyst recommendations and institutional ownership. Analyst Recommendations This is a breakdown of recent